San Francisco arts hub is looking for a new home
State of play: The non-profit has been renting its Bayview warehouse from SFUSD for the past 25 years, but the building is slated for demolition in 2026 to make way for a central kitchen for the school district.
Zoom in: The warehouse is a treasure trove for artists, creatives, teachers and anyone looking to start a project. On any given day you might find bolts of fabric, sport trophies, mannequins, school supplies or a box full of Mardi Gras beads.
What they're saying: "We're looking to find a place that we can eventually buy so that we can have a forever home… a warm, vibrant and welcoming space for our constituents," said Scrap programs director Danielle Grant.
The ideal space would have 10,000 square feet with parking, Grant said.
My thought bubble: Scrap is my favorite kind of creative place — full of weird odds and ends and so much inspiration. I picked up some great vintage typography stickers designed to stick up in shop windows.
Be prepared — you won't go home empty-handed.
The bottom line:"It's a unique shopping experience," Grant said. "If you have something in mind, you might not get it… This is a place where you come to discover things that you didn't think you were going to find."
If you go: Open from 10am to 6pm Tuesday through Sunday at 2150 Newcomb Ave.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
a day ago
- Associated Press
CardoMax Acquired by Cardone Ventures, Marking a New Era in High-Performance Nutrition
Miami, FL August 12, 2025 --( )-- CardoMax, the innovative liquid-based supplement company founded by former Navy SEALs, has been acquired by Cardone Ventures, the leading business growth and investment firm founded by Grant Cardone and Brandon Dawson. This acquisition marks a significant step in the evolution of performance nutrition, bringing CardoMax's proprietary AAT® Accelerated Absorption Technology® under the umbrella of Cardone Ventures' expanding health and wellness portfolio. CardoMax's single-serve, liquid-based supplements have revolutionized the industry by delivering nutrients up to 20 times faster and 3 times more efficiently than traditional supplement forms. Initially, CardoMax partnered with 10X Health System, a subsidiary of Cardone Ventures, by white-labeling its unique formulations. The success of that collaboration led to this acquisition, ensuring deeper integration and wider accessibility for consumers seeking elite performance and peak vitality. 'From day one, our mission at CardoMax has been to provide people with the most efficient and effective way to fuel their bodies,' said Sean Matson, Co-Founder & CEO of CardoMax. 'By joining forces with Cardone Ventures, we're taking this mission to the next level—scaling faster, innovating further, and ensuring our game-changing formulas reach even more people.' With this acquisition, Cardone Ventures is doubling down on its commitment to disrupt the health and wellness space with high-impact, results-driven solutions. 'CardoMax represents the kind of innovative thinking and market leadership that aligns perfectly with our vision,' said Brandon Dawson, CEO of Cardone Ventures. 'By bringing them fully into the Cardone Ventures ecosystem, we're not just investing in a brand—we're investing in a movement that empowers people to take control of their health with the highest-quality supplements on the market.' The integration of CardoMax's proprietary technology into 10X Health System and beyond will expand its reach, accelerate product development, and drive new advancements in performance supplementation. Together, CardoMax and Cardone Ventures are setting a new standard for next-level health, energy, and performance. For more information, visit and Disclaimer: The statements herein have not been evaluated by the Food and Drug Administration. The products mentioned herein are not intended to diagnose, treat, cure, or prevent any disease. About CardoMax Founded by former Navy SEALs, CardoMax is a pioneer in liquid-based supplements designed for maximum absorption and efficiency. Using AAT® Accelerated Absorption Technology®, CardoMax's formulas deliver faster, cleaner, and more effective performance-enhancing nutrition. About Cardone Ventures & 10X Health Systems Cardone Ventures, co-founded by Brandon and Natalie Dawson, in partnership with Grant Cardone, is a business growth firm dedicated to helping entrepreneurs scale and optimize their businesses through strategic investments and leadership development. 10X Health Systems, a subsidiary of Cardone Ventures, is on a mission to maximize human performance through precision genetic testing, personalized health optimization plans, and innovative supplement solutions. By combining cutting-edge science with elite business strategy, Cardone Ventures and 10X Health Systems are redefining what's possible in the world of entrepreneurial health and high-performance living. Contact Information: CardoMax Lisa De Rosa 480-376-1990 Contact via Email Read the full story here: CardoMax Acquired by Cardone Ventures, Marking a New Era in High-Performance Nutrition Press Release Distributed by
Yahoo
2 days ago
- Yahoo
Britain's biggest toy shop chain handed over to staff
The founder of Britain's biggest toy shop chain has handed the company over to its employees. Gary Grant, founder of The Entertainer, is preparing to transfer his family's 100pc ownership of the firm to an employee ownership trust (EOT), with the transfer to be completed next month. The move exempts his family from potential death duties ahead of Rachel Reeves's inheritance tax (IHT) raid. The retailer said the step would 'ensure the group remains independent with its employees as beneficiaries, while preserving both the family's legacy and the family feel of the business'. It comes amid a shake-up of IHT rules by the Government, which will cap tax relief on family businesses handed down to descendants at £1m from April next year, resulting in higher bills for those inheriting businesses. Under the previous system, company owners could leave assets to their families without paying death duties. The reforms, announced by Rachel Reeves, the Chancellor, in her maiden Budget last October, were designed to clamp down on tax avoidance and raise money for public services. However, they have outraged the owners of many family businesses, who argue that the changes will result in soaring IHT bills that could force their descendants to sell up. While the change at The Entertainer will allow the Grant family to avoid higher death duties, it is understood that exempting the company from IHT was not the sole motivating factor in moving the toy chain into employee ownership. Mr Grant said the decision had not been 'taken lightly'. He added: 'We couldn't be more proud that this still remains at the heart of the business today, thanks to the daily enthusiasm of our staff – many of whom have worked for us for many years. Because of this, ensuring our employees have a place in the Group's future is hugely important to us.' Under the EOT model, a controlling stake in The Entertainer will transfer to a trust which is indirectly owned by the employees, removing the need for staff to actually purchase shares themselves. The Grant family will receive payments for the business out of its future profits, although the company did not disclose a valuation. Any proceeds received by the Grant family will be tax-free. Advocates of employee ownership say it rewards staff better, increases loyalty and productivity. Examples of prominent businesses that use this model include the John Lewis Partnership and retail chain Richer Sounds. James de la Vingne, the chief executive of the Employee Ownership Association, said there was 'a growing trend for retailers making the move to employee ownership alongside calls to help save the high street'. Founded in Buckinghamshire in 1981, The Entertainer today runs more than 160 stores across the country and over 1,000 concessions in stores such as Tesco, Matalan and Marks & Spencer. As well as its eponymous stores, it owns the Early Learning Centre and Addo brands. The Grant family were paid a £15.62m divided during 2023, according to the latest available accounts for The Entertainer's parent company Teal Group Holdings, despite a fall in both sales and profits. Last November, Andrew Murphy, The Entertainer's chief executive, said the company had been forced to cancel two new store openings because of higher National Insurance contributions levied on employers in Ms Reeves's Budget. Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.
Yahoo
6 days ago
- Yahoo
EpiPen patent expiry opens new era for innovation
The upcoming EpiPen patent expiration on 11 September 2025 sets the stage for a pivotal shift in the epinephrine delivery market. Mylan acquired the rights to the injector pen for treating anaphylactic reactions following the $6.7bn acquisition of Merck KGaA's generics business, Merck Generics, in 2007. Mylan has since faced criticism for inflating the price of EpiPen and constraining patient access. The company has faced numerous lawsuits over the years in relation to overcharging drug wholesalers for access. In 2020, Mylan merged with Upjohn, Pfizer's off-patent medicine division, to form Viatris. In January 2025, Mylan reached a $73.5m settlement with KPH Healthcare Services following accusations that it conspired with Pfizer and Teva Pharmaceuticals to delay the release of generic EpiPens, thereby maintaining a monopoly and inflating prices for epinephrine autoinjectors. The lawsuit contested that prices for a two-pack of EpiPens rose from around $100 in 2008 to $600 during the class period between March 2014 and February 2025. The generics upswell and innovation rise According to Dr Stuart Grant, principal consultant at UK-based medtech consultant Archetype MedTech, the patent expiration's immediate effect will lead to a rise in generic competitors. 'An increase in generic options is likely to lower prices considerably, expanding choices for consumers and healthcare providers. Greater availability of affordable options could improve access for individuals and families who previously found it too expensive,' Grant said. With the patent expiration, Grant foresees Viatris facing pressures to cut prices or introduce new financial support programmes to maintain its market share. 'The brand might also explore developing next-generation devices, improving user experience, or applying for secondary patents to stay competitive. These strategies, known as 'evergreening', could draw regulatory attention depending on their intent and market impact,' Grant explained. Epinephrine injector competitors have previously had to develop their devices around EpiPen's patented spring-loaded mechanism, a reality that limited their ability to replicate or improve upon the core delivery system. 'They will now be able to use the original design as a foundation, incorporating enhancements such as better ergonomics, child-friendly features, or smaller form factors,' Grant said. 'The removal of patent barriers also paves the way for innovative technologies – Bluetooth tracking, dose reminders, and digital health integrations can now be layered on top of the legacy design. 'Moreover, companies can explore alternative formulations and delivery methods while leveraging the expired EpiPen model for regulatory efficiency, potentially qualifying for accelerated approval pathways. This reduces both development time and cost, encouraging new entrants into the market.' Grant concluded. "EpiPen patent expiry opens new era for innovation" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
